6q deletions define distinct clinico-pathologic subsets of non- Hodgkin's lymphoma
Authors:
Open Access
- 1 October 1993
- journal article
- Published by American Society of Hematology in Blood
- Vol. 82 (7) , 2157-2162
Abstract
Commonly observed in lymphoid neoplasms, deletions of 6q have been correlated with histologic and clinical subsets of non-Hodgkin's lymphoma (NHL). Our recent analysis of loss of heterozygosity of 6q loci in NHL showed two regions of minimal molecular deletion (RMD), an RMD1 at 6q25–27 and an RMD2 at 6q21–23. To establish correlations between these RMDs and regions of minimal cytogenetic deletions (RCDs) on 6q, and to define associations between RCDs and clinico-pathologic features, we have analyzed chromosome 6 abnormalities in 459 consecutively ascertained, karyotypically abnormal cases of NHL. Among these, 126 (27.5%) cases had structural abnormalities of chromosome 6, of which 94 were deletions. Analysis of these deletions identified three RCDs. An RCD1 encompassing 6q25–27 was seen in 45 intermediate- grade NHL. An RCD2 at 6q21 was observed in 11 high-grade NHL, 9 of which were of the immunoblastic subtype. An RCD3 at 6q23 was noted in 18 low-grade NHL lacking a t(14;18) translocation. Of these 18 cases, 12 were small lymphocytic NHL and, in 2 of these, del(6q) was the sole karyotypic abnormality. In 20 cases of low-grade NHL with t(14;18), the deletions spanned both RCD1 and RCD3. These data suggested the presence of at least 3 tumor suppressor genes on 6q within RCD1, RCD2, and RCD3; they also showed associations between RCDs in 6q and subsets of NHL, including a specific association between a group of well-differentiated lymphoid neoplasms and RCD3. The apparent heterogeneity of breakpoints when all NHLs are considered together explains the inability of previous studies to reliably establish correlations between recurring 6q deletions and histologic and clinical features of NHL.Keywords
This publication has 11 references indexed in Scilit:
- Subregional Localization of 20 Single-Copy Loci to Chromosome 6 by Fluorescence in Situ HybridizationGenomics, 1993
- The use of synthetic tandem repeats to isolate new VNTR loci: Cloning of a human hypermutable sequenceGenomics, 1991
- Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphomaCancer Genetics and Cytogenetics, 1990
- Chromosome aberrations in B-cell chronic lymphocytic leukemiaCancer Genetics and Cytogenetics, 1990
- Chromosome abnormalities in chronic lymphocytic leukemia revealed by cytochalasin B and Epstein-Barr virusCancer Genetics and Cytogenetics, 1987
- Multiple Recurrent Genomic Defects in Follicular LymphomaNew England Journal of Medicine, 1987
- Fluorescent bodies in lymphocytes in chronic lymphocytic leukemiaCancer Genetics and Cytogenetics, 1985
- Prognostic Importance of Cytogenetic Abnormalities in Patients with Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1984
- Prognostic implications of karyotype and morphology in patients with non‐Hodgkin's lymphomaInternational Journal of Cancer, 1983
- Lymphoblastic lymphoma: Cytogenetic, pathologic, and immunologic studiesInternational Journal of Cancer, 1982